Altered expression of the ERM proteins in lung adenocarcinoma

Laboratory Investigation

Volumn 80, Issue 11, 2000, Pages 1643-1650

  Tokunou, Masahide ^a,b   Niki, Toshiro ^a   Saitoh, Yukihito ^b   Imamura, Hiroji ^b   Sakamoto, Michiie ^a   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EZRIN; MOESIN; RADIXIN;

ARTICLE; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 0033730052     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780174     Document Type: Article

References (55)

1. High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential
2. Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker
3. Regulation of p53 stability
4. Identification of differentially expressed mRNA species by an improved display technique (DDRT-PCR)
5. Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor
6. Ezrin: A protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures
7. Loss of heterozygosity at 11q22-q23 in breast cancer
8. Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells
9. Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer
10. A novel method for real time quantitative RT-PCR
11. Loss of heterozygosity in sporadic human breast carcinoma: A common region between 11q22 and 11q23.3
12. Loss of heterozygosity in cervical carcinoma: Subchromosomal localization of a putative tumor suppressor gene to chromosome 11q22-q24
13. Real time quantitative PCR
14. Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2): Regulation by phosphatidylinositol 4:5-bisphosphate
15. Molecular dissection of radixin: Distinct and interdependent functions of the amino- and carboxy-terminal domains
16. A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma
17. Neurofibromatosis 2 antisense oligodeoxynucleotides induce reversible inhibition of schwannomin synthesis and cell adhesion in STS26T and T98G cells
18. Moesin and CD44 expression in cutaneous melanocytic tumours
19. Allelic losses in human chromosome 11 in lung cancers
20. Nuclear p53 accumulation by small-sized adenocarcinomas of the lung
21. 11q deletions in human colorectal carcinomas: Cytogenetics and restriction fragment length polymorphism analysis
22. Proliferative potential and p53 overexpression in precursor and early-stage lesions of bronchioloalveolar lung carcinoma
23. Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study
24. Moesin: A member of the protein 4.1-talin-ezrin family of proteins
25. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells
26. Distribution and cloning of eukaryotic mRNAs by means of differential display: Refinements and optimization
27. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction
28. The neurofibromatosis type 2 gene product, schwannomin, suppresses growth of NIH 3T3 cells
29. ERM proteins in cell adhesion and membrane dynamics
30. Ezrin NH2-terminal domain inhibits the cell extension activity of the COOH-terminal domain
31. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: Identification of a new region at 11q23.3
32. Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: Studies on chromosomes 6 and 11
33. Small adenocarcinoma of the lung: Histologic characteristics and prognosis
34. Complementation of a DNA repair deficiency in six human tumor cell lines by chromosome 11
35. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: Identification of three independent regions
36. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2
37. CD44 and the adhesion of neoplastic cells
38. Identification by differential display of alpha 6 integrin as a candidate tumor suppressor gene
39. A gene family consisting of ezrin, radixin and moesin: Its specific localization at actin filament/plasma membrane association sites
40. Radixin, a barbed end-capping actin-modulating protein, is concentrated at the cleavage furrow during cytokinesis
41. Suppression of tumorigenicity of A549 lung adenocarcinoma cells by human chromosomes 3 and 11 introduced via microcell-mediated chromosome transfer
42. Universal absence of merlin, but not other ERM family members, in schwannomas
43. Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.3-923.1 in lymphoproliferative disorders
44. An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin)
45. A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer
46. A novel moesin, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
47. A new 82-kD barbed end-capping protein (radixin) localized in the cell-to-cell adherens junction: Purification and characterization
48. Submembranous junctional plaque proteins include potential tumor suppressor molecules
49. Possible involvement of adherens junction plaque proteins in tumorigenesis and metastasis
50. Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family
51. Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer
52. Molecular cloning, cDNA sequence, and chromosomal assignment of the human radixin gene and two dispersed pseudogenes
53. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis
54. Ezrin/radixin/moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2
55. Differential display with carboxy-X-rhodamine-labeled primers and the selection of differentially amplified cDNA fragments without cloning